SCI Abstract

search
+
Early detection of pancreatic cancer
Early detection of pancreatic cancer
Background: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy that is increasingly common. Screening for...
OnkoImmun 18
OnkoImmun 18
Oncology Rese...
Identification and validation of CCNA2 and CCNE2 as potential biomarkers in small cell lung cancer
Identification and validation of CCNA2 and CCNE2 as potential biomarkers in small cell lung cancer
Introduction: Small cell lung cancer (SCLC) is a special type of lung cancer sensitive to radiotherapy and chemotherapy bu...
Early versus delayed tumor specific therapy and survival in patients with lung cancer: a retrospective study
Early versus delayed tumor specific therapy and survival in patients with lung cancer: a retrospective study
Introduction: The timing of tumor specific palliative therapy and its influence on the survival of patients with stage IV ...
Quality measurement for soft tissue sarcomas in Germany – first results of the Certified Sarcoma Centres
Quality measurement for soft tissue sarcomas in Germany – first results of the Certified Sarcoma Centres
Introduction: Soft tissue sarcomas (STS) are rare diseases. A high level of standardization and centralisation was lacking...
Changes In Tumor Immune Microenvironment After Radiotherapy Resistance In Colorectal Cancer: a Narrative Review
Changes In Tumor Immune Microenvironment After Radiotherapy Resistance In Colorectal Cancer: a Narrative Review
Background: Colorectal cancer (CRC) is a common digestive tract malignancy with high incidence and mortality rates. Radiot...
Association between resting heart rate and oncological outcomes in patients with early-stage cervical cancer who have undergone radical hysterectomy with pelvic lymphadenectomy
Association between resting heart rate and oncological outcomes in patients with early-stage cervical cancer who have undergone radical hysterectomy with pelvic lymphadenectomy
Introduction: A few studies have explored the association of resting heart rate (RHR) with mortality and/or other oncologi...
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation
Durable Response after Olaparib Treatment for Perihilar Cholangiocarcinoma with Germline BRCA2 Mutation
Introduction: Despite major advances in surveillance and management, advanced cholangiocarcinoma (CCA) still carries a dis...
High in-hospital mortality in SARS-CoV-2 infected patients with active cancer disease during Omicron phase of the pandemic – Insights from the CORONA Germany Study
High in-hospital mortality in SARS-CoV-2 infected patients with active cancer disease during Omicron phase of the pandemic – Insights from the CORONA Germany Study
Introduction: SARS-CoV-2 infected patients with cancer have a worse outcome including a significant higher mortality, comp...
Expert Report on Immune Thrombocytopenia - Current Diagnostics and Treatment Recommendations from an Expert Group from Austria, Germany, and Switzerland
Expert Report on Immune Thrombocytopenia - Current Diagnostics and Treatment Recommendations from an Expert Group from Austria, Germany, and Switzerland
no Abstract
Patterns of care and survival in cancer patients with brain metastases receiving immune checkpoint inhibitors
Patterns of care and survival in cancer patients with brain metastases receiving immune checkpoint inhibitors
Introduction: Immune checkpoint inhibitors (ICI) have become a mainstay of treatment for different cancer types. The purpo...
Oncology in Europe
Oncology in Europe
usually not provided for an editorial
Circulating glypican-4 is a predictor of 24-month overall survival in metastatic breast cancer
Circulating glypican-4 is a predictor of 24-month overall survival in metastatic breast cancer
Background & objective: Endocrine treatment combined with CDK4/6 inhibitors is the preferred treatment strategy in pat...
Impact of Geriatric Assessment on the Tolerability of Combination Chemotherapy in Older Patients with Advanced Cancer: A Matched-Pair Analysis
Impact of Geriatric Assessment on the Tolerability of Combination Chemotherapy in Older Patients with Advanced Cancer: A Matched-Pair Analysis
Because of their individual vulnerabilities, treatment decisions for older patients can be difficult. Geriatric assessment...
Clinical outcome and treatment sequences of patients with advanced pancreatic cancer treated with contemporary chemotherapy protocols
Clinical outcome and treatment sequences of patients with advanced pancreatic cancer treated with contemporary chemotherapy protocols
Introduction Systemic therapy is firmly established in patients with advanced or metastatic pancreatic ductal adenocarcino...
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial
Effects of a Sound Intervention on Physical and Emotional Well-Being in Patients with Cancer: A Prospective Randomized Trial
<b><i>Aim:</i></b> Cancer remains a disease with a significant impact on morbidity and mortality b...
Exercise as medicine could be a chance for early detection and prevention of Cardiotoxicity in cancer treatments – a narrative review
Exercise as medicine could be a chance for early detection and prevention of Cardiotoxicity in cancer treatments – a narrative review
Background: For cancer patients, cardiovascular complications as a consequence of certain oncological therapies are the le...
Medical oncology education in Europe: equipping medical oncologists to provide the best care for patients with cancer
Medical oncology education in Europe: equipping medical oncologists to provide the best care for patients with cancer
Abstract High quality, evidence-based and practice relevant education is essential to equip medical oncologists to provid...
A phase II study of nab-paclitaxel and gemcitabine as first line therapy in patients with cholangiocarcinoma ineligible for cisplatin-based chemotherapy (NACHO)
A phase II study of nab-paclitaxel and gemcitabine as first line therapy in patients with cholangiocarcinoma ineligible for cisplatin-based chemotherapy (NACHO)
Introduction: Gemcitabine and cisplatin is the standard 1st line systemic treatment in patients with advanced cholangiocar...
format_indent_increase